top of page

Tirzepatide

Tirzepatide: Dual-Action Weight Loss & Metabolic Health
Tirzepatide is a dual GLP-1/GIP receptor agonist that significantly enhances weight loss and metabolic health. On average, users experience a 15–22.5% reduction in body weight with the added benefits of improved insulin sensitivity and cardiovascular support.

Tirzepatide – Advanced Weight Loss and Metabolic Health


At Metamorphosis, we offer Tirzepatide, a revolutionary peptide therapy designed to target both GLP-1 and GIP receptors, making it a dual-action treatment that enhances weight loss and metabolic function. This advanced therapy leads to significant weight loss, with patients experiencing an average reduction of 15–22.5% of body weight, surpassing the effectiveness of other GLP-1 treatments such as Semaglutide.


Key benefits of Tirzepatide include:

  • Greater weight loss compared to Semaglutide

  • Enhanced insulin sensitivity and improved glucose regulation

  • Cardiovascular benefits, including improved lipid profiles

  • Supports overall metabolic health and fat burning


Tirzepatide works by helping regulate appetite, increase energy expenditure, and reduce hunger, providing a comprehensive approach to weight loss and long-term metabolic health.


Monthly Program Includes

1:1 coaching to guide you through your journey

Sample meal plans tailored to support your weight loss goals


Medication support to ensure proper usage and results

To begin treatment, recent blood work (within the last 3–6 months) is required. Outside lab work is accepted.


Unlock the power of dual-action therapy for lasting weight loss and improved metabolic health with Tirzepatide.

bottom of page